semaglutide and ibd GLP-1 obesity "inflammatory bowel disease" Semaglutide in IBD Patients with

Oral administration subjects the peptide to gastric degradation, which is why most peptides cannot be taken orally

Semaglutide, marketed under the brand name Ozempic for diabetes and Wegovy for weight loss, is a once-weekly injectable medication already approved by the FDA for weight management

GLP-1 and GIP are incretin hormones that stimulate insulin secretion after an oral glucose load by binding GLP-1R, but both are rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4)

J Nutr Sci vitaminol (1999) 45:77383

What If Compounded Semaglutide Isnt Available in Your State

The relationship between rapid glucose lowering and retinal complications is not new